Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab. Selleri C, Serio B, Risitano AM Mini Rev Med Chem. 2011 Jun; 11(6):536-43. PMID: 21561402. Abstract CommentRecommendBookmarkWatch